Correlation Between Metalpha Technology and Omega Therapeutics
Can any of the company-specific risk be diversified away by investing in both Metalpha Technology and Omega Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Metalpha Technology and Omega Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Metalpha Technology Holding and Omega Therapeutics, you can compare the effects of market volatilities on Metalpha Technology and Omega Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Metalpha Technology with a short position of Omega Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Metalpha Technology and Omega Therapeutics.
Diversification Opportunities for Metalpha Technology and Omega Therapeutics
0.28 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Metalpha and Omega is 0.28. Overlapping area represents the amount of risk that can be diversified away by holding Metalpha Technology Holding and Omega Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Omega Therapeutics and Metalpha Technology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Metalpha Technology Holding are associated (or correlated) with Omega Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Omega Therapeutics has no effect on the direction of Metalpha Technology i.e., Metalpha Technology and Omega Therapeutics go up and down completely randomly.
Pair Corralation between Metalpha Technology and Omega Therapeutics
Given the investment horizon of 90 days Metalpha Technology Holding is expected to generate 0.75 times more return on investment than Omega Therapeutics. However, Metalpha Technology Holding is 1.33 times less risky than Omega Therapeutics. It trades about -0.21 of its potential returns per unit of risk. Omega Therapeutics is currently generating about -0.26 per unit of risk. If you would invest 117.00 in Metalpha Technology Holding on August 27, 2024 and sell it today you would lose (24.00) from holding Metalpha Technology Holding or give up 20.51% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Metalpha Technology Holding vs. Omega Therapeutics
Performance |
| Timeline |
| Metalpha Technology |
| Omega Therapeutics |
Metalpha Technology and Omega Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Metalpha Technology and Omega Therapeutics
The main advantage of trading using opposite Metalpha Technology and Omega Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Metalpha Technology position performs unexpectedly, Omega Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Omega Therapeutics will offset losses from the drop in Omega Therapeutics' long position.| Metalpha Technology vs. Omega Therapeutics | Metalpha Technology vs. Metalink | Metalpha Technology vs. Aquagold International | Metalpha Technology vs. Morningstar Unconstrained Allocation |
| Omega Therapeutics vs. Pmv Pharmaceuticals | Omega Therapeutics vs. Eliem Therapeutics | Omega Therapeutics vs. MediciNova | Omega Therapeutics vs. Pharvaris BV |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Complementary Tools
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Stocks Directory Find actively traded stocks across global markets | |
| CEOs Directory Screen CEOs from public companies around the world |